Physician profile
Kyle Mesa
NPI 1114633153
$1,518.69
in general payments reported to CMS, 2019-2025
14 companies · $817 in 2025
The $817 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $322 · 2024: $380 · 2025: $817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,518.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $321.31 | 2023-2025 | |
| Vericel Corporation | $276.80 | 2024-2025 | Maci |
| Endo USA, INC. | $182.08 | 2025 | Xiaflex |
| Suvon Surgical LLC | $168.72 | 2025 | |
| Baxter Healthcare | $150.00 | 2024 | Starling System |
| Acumed LLC | $120.88 | 2023 | Acumed |
| Vertex Pharmaceuticals Incorporated | $104.73 | 2024-2025 | |
| Stryker Corporation | $41.88 | 2025 | Pangea |
| Avanos Medical | $37.67 | 2025 | Standard Rf Disposables |
| Convatec INC. | $32.17 | 2024 | |
| Linvatec Corporation | $28.31 | 2025 | Linvatec Arthroscopy |
| Axogen | $25.17 | 2025 | |
| Endo Pharmaceuticals INC. | $14.59 | 2023 | Xiaflex |
| Heron Therapeutics, INC. | $14.38 | 2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Mesa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.